Claudia Neuhauser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Claudia Neuhauser has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- David Dingli
Division of Hematology, Mayo Clinic, Rochester, USA
4 shared publications Iris Kemler
Molecular Medicine, Mayo Clinic, Rochester, Minnesota
4 shared publications- Adam G. Schrum
Department of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA
3 shared publications N. Lanchier
3 shared publicationsSteven C. Neier
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School
3 shared publicationsAntony M. Dean
College of Ecology and Evolution, Sun Yat-sen University, Guangzhau, China
2 shared publications
Latest Publications
- Open Access
- 27 June 2025
- Published by Wiley in Clinical and Translational Science
- Vol. 18 (7) , e70259
A Survey Study of Roadblocks in Translational Science
Clinical and translational science needs to address roadblocks to the translational processes. We conducted a survey at two institutions, a private medical school and a large public university, to understand the frequency and distribution of barriers and roadblocks to research. We reviewed the literature to compile a pool of barriers and roadblocks and convened a panel of relevant stakeholders to develop a 20‐item questionnaire. Survey respondents were asked to select and prioritize the five leading clinical and translational roadblocks, provide information regarding their academic degrees and rank/position, complete open‐ended items regarding their areas of research, and optionally add additional remarks in a comment box. The survey was disseminated in August 2022 to faculty and staff with active research protocols at Baylor College of Medicine and the University of Houston. In total, 227 respondents completed the survey. Their disciplines were basic science (29.5%), translational research (52.9%), clinical research (55.5%), community‐engaged research (9.7%), and educational research (9.7%). Respondents identified (1) lack of access to trained research coordinators, (2) lack of understanding about different resources that facilitate research, (3) complex regulatory environment and delays, (4) fragmented infrastructure for administrative and fiscal processes, and (5) inadequate funding for pilot projects to foster new research. Other roadblocks included lack of established community stakeholder partnerships, inadequate access to medical record data, and limited biostatistical support. We identified leading roadblocks to research from the perspectives of scientists and staff conducting clinical and translational research. Operational innovations addressing these roadblocks can accelerate the pace of translation.
- 27 June 2025
- Published by Wiley in Clinical and Translational Science
- Vol. 18 (7) , e70259
Open AccessA Survey Study of Roadblocks in Translational Science
Clinical and translational science needs to address roadblocks to the translational processes. We conducted a survey at two institutions, a private medical school and a large public university, to understand the frequency and distribution of barriers and roadblocks to research. We reviewed the literature to compile a pool of barriers and roadblocks and convened a panel of relevant stakeholders to develop a 20‐item questionnaire. Survey respondents were asked to select and prioritize the five leading clinical and translational roadblocks, provide information regarding their academic degrees and rank/position, complete open‐ended items regarding their areas of research, and optionally add additional remarks in a comment box. The survey was disseminated in August 2022 to faculty and staff with active research protocols at Baylor College of Medicine and the University of Houston. In total, 227 respondents completed the survey. Their disciplines were basic science (29.5%), translational research (52.9%), clinical research (55.5%), community‐engaged research (9.7%), and educational research (9.7%). Respondents identified (1) lack of access to trained research coordinators, (2) lack of understanding about different resources that facilitate research, (3) complex regulatory environment and delays, (4) fragmented infrastructure for administrative and fiscal processes, and (5) inadequate funding for pilot projects to foster new research. Other roadblocks included lack of established community stakeholder partnerships, inadequate access to medical record data, and limited biostatistical support. We identified leading roadblocks to research from the perspectives of scientists and staff conducting clinical and translational research. Operational innovations addressing these roadblocks can accelerate the pace of translation.
- 8 October 2021
- Published by SAGE Publications in Psychology of Music
- Vol. 50 (4) , 1328-1339
The effects of group keyboard music making on the mood states of college students
Our pilot study explored the effects of a new, five-session group keyboard music-making protocol on the mood states of non-musician college students. Twenty-five math and engineering students participated in a keyboard music-making program without the expectation or need for extensive technical preparation or regular music practice. To assess changes in mood states before and after music-making activities, we administered the Profile of Mood States-Short Form (POMS-SF) questionnaire. Here, we show significant and lasting improvements in participant’s negative and positive mood states, which were more robust than mood improvements reported with other Recreational Music Making (RMM) protocols, suggesting a strong therapeutic potential of our group keyboard music-making program.
- 8 October 2021
- Published by SAGE Publications in Psychology of Music
- Vol. 50 (4) , 1328-1339
The effects of group keyboard music making on the mood states of college students
Our pilot study explored the effects of a new, five-session group keyboard music-making protocol on the mood states of non-musician college students. Twenty-five math and engineering students participated in a keyboard music-making program without the expectation or need for extensive technical preparation or regular music practice. To assess changes in mood states before and after music-making activities, we administered the Profile of Mood States-Short Form (POMS-SF) questionnaire. Here, we show significant and lasting improvements in participant’s negative and positive mood states, which were more robust than mood improvements reported with other Recreational Music Making (RMM) protocols, suggesting a strong therapeutic potential of our group keyboard music-making program.
- 21 August 2019
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 150,p. e60029
Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
Dynamic protein-protein interactions control cellular behavior, from motility to DNA replication to signal transduction. However, monitoring dynamic interactions among multiple proteins in a protein interaction network is technically difficult. Here, we present a protocol for Quantitative Multiplex Immunoprecipitation (QMI), which allows quantitative assessment of fold changes in protein interactions based on relative fluorescence measurements of Proteins in Shared Complexes detected by Exposed Surface epitopes (PiSCES). In QMI, protein complexes from cell lysates are immunoprecipitated onto microspheres, and then probed with a labeled antibody for a different protein in order to quantify the abundance of PiSCES. Immunoprecipitation antibodies are conjugated to different MagBead spectral regions, which allows a flow cytometer to differentiate multiple parallel immunoprecipitations and simultaneously quantify the amount of probe antibody associated with each. QMI does not require genetic tagging and can be performed using minimal biomaterial compared to other immunoprecipitation methods. QMI can be adapted for any defined group of interacting proteins, and has thus far been used to characterize signaling networks in T cells and neuronal glutamate synapses. Results have led to new hypothesis generation with potential diagnostic and therapeutic applications. This protocol includes instructions to perform QMI, from the initial antibody panel selection through to running assays and analyzing data. The initial assembly of a QMI assay involves screening antibodies to generate a panel, and empirically determining an appropriate lysis buffer. The subsequent reagent preparation includes covalently coupling immunoprecipitation antibodies to MagBeads, and biotinylating probe antibodies so they can be labeled by a streptavidin-conjugated fluorophore. To run the assay, lysate is mixed with MagBeads overnight, and then beads are divided and incubated with different probe antibodies, and then a fluorophore label, and read by flow cytometry. Two statistical tests are performed to identify PiSCES that differ significantly between experimental conditions, and results are visualized using heatmaps or node-edge diagrams.
- 21 August 2019
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 150,p. e60029
Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
Dynamic protein-protein interactions control cellular behavior, from motility to DNA replication to signal transduction. However, monitoring dynamic interactions among multiple proteins in a protein interaction network is technically difficult. Here, we present a protocol for Quantitative Multiplex Immunoprecipitation (QMI), which allows quantitative assessment of fold changes in protein interactions based on relative fluorescence measurements of Proteins in Shared Complexes detected by Exposed Surface epitopes (PiSCES). In QMI, protein complexes from cell lysates are immunoprecipitated onto microspheres, and then probed with a labeled antibody for a different protein in order to quantify the abundance of PiSCES. Immunoprecipitation antibodies are conjugated to different MagBead spectral regions, which allows a flow cytometer to differentiate multiple parallel immunoprecipitations and simultaneously quantify the amount of probe antibody associated with each. QMI does not require genetic tagging and can be performed using minimal biomaterial compared to other immunoprecipitation methods. QMI can be adapted for any defined group of interacting proteins, and has thus far been used to characterize signaling networks in T cells and neuronal glutamate synapses. Results have led to new hypothesis generation with potential diagnostic and therapeutic applications. This protocol includes instructions to perform QMI, from the initial antibody panel selection through to running assays and analyzing data. The initial assembly of a QMI assay involves screening antibodies to generate a panel, and empirically determining an appropriate lysis buffer. The subsequent reagent preparation includes covalently coupling immunoprecipitation antibodies to MagBeads, and biotinylating probe antibodies so they can be labeled by a streptavidin-conjugated fluorophore. To run the assay, lysate is mixed with MagBeads overnight, and then beads are divided and incubated with different probe antibodies, and then a fluorophore label, and read by flow cytometry. Two statistical tests are performed to identify PiSCES that differ significantly between experimental conditions, and results are visualized using heatmaps or node-edge diagrams.
- Open Access
- 28 July 2019
- Published by Association for Computing Machinery (ACM)
- p. 1-3
A Comprehensive Campus-based Approach to Address the Opportunities and Challenges Posed by Data Intensive Research
- 28 July 2019
- Published by Association for Computing Machinery (ACM)
- p. 1-3
Open AccessA Comprehensive Campus-based Approach to Address the Opportunities and Challenges Posed by Data Intensive Research
- Open Access
- 5 March 2019
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 15 (3) , e1006773
In vitro and in silico multidimensional modeling of oncolytic tumor virotherapy dynamics
Tumor therapy with replication competent viruses is an exciting approach to cancer eradication where viruses are engineered to specifically infect, replicate, spread and kill tumor cells. The outcome of tumor virotherapy is complex due to the variable interactions between the cancer cell and virus populations as well as the immune response. Oncolytic viruses are highly efficient in killing tumor cells in vitro, especially in a 2D monolayer of tumor cells, their efficiency is significantly lower in a 3D environment, both in vitro and in vivo. This indicates that the spatial dimension may have a major influence on the dynamics of virus spread. We study the dynamic behavior of a spatially explicit computational model of tumor and virus interactions using a combination of in vitro 2D and 3D experimental studies to inform the models. We determine the number of nearest neighbor tumor cells in 2D (median = 6) and 3D tumor spheroids (median = 16) and how this influences virus spread and the outcome of therapy. The parameter range leading to tumor eradication is small and even harder to achieve in 3D. The lower efficiency in 3D exists despite the presence of many more adjacent cells in the 3D environment that results in a shorter time to reach equilibrium. The mean field mathematical models generally used to describe tumor virotherapy appear to provide an overoptimistic view of the outcomes of therapy. Three dimensional space provides a significant barrier to efficient and complete virus spread within tumors and needs to be explicitly taken into account for virus optimization to achieve the desired outcome of therapy. Tumor therapy with replicating oncolytic viruses is based on the premise that if the tumor specific virus infects and is amplified by the tumor population and spreads sufficiently within the tumor, it will lead to eradication of the cancer. The outcome of this approach is an exercise in population dynamics, and, as in ecology, depends on the detailed interactions between the various players involved. Mathematical models have been used to capture these dynamics, but space is often explicitly excluded from these models. We combine in vitro experiments studying tumor growth and virus spread in two and three dimensions to inform the development of a spatially explicit computational model of tumor virotherapy and compare the outcome with non-spatial, mean-field models. Viruses generally spread from cell to cell, and therefore the number of nearest neighbors close to an infected cell is important. Experimental data show that in three dimensions, the median number of nearest neighbors is 16 compared to 6 in the 2D plane. However, while simulations in 3D reach equilibrium faster than in 2D, tumor eradication is much less common in 3D than in 2D. Three dimensional space plays a critical role in the outcome of tumor virotherapy and this additional spatial dimension cannot be ignored in modeling.
- 5 March 2019
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 15 (3) , e1006773
Open AccessIn vitro and in silico multidimensional modeling of oncolytic tumor virotherapy dynamics
Tumor therapy with replication competent viruses is an exciting approach to cancer eradication where viruses are engineered to specifically infect, replicate, spread and kill tumor cells. The outcome of tumor virotherapy is complex due to the variable interactions between the cancer cell and virus populations as well as the immune response. Oncolytic viruses are highly efficient in killing tumor cells in vitro, especially in a 2D monolayer of tumor cells, their efficiency is significantly lower in a 3D environment, both in vitro and in vivo. This indicates that the spatial dimension may have a major influence on the dynamics of virus spread. We study the dynamic behavior of a spatially explicit computational model of tumor and virus interactions using a combination of in vitro 2D and 3D experimental studies to inform the models. We determine the number of nearest neighbor tumor cells in 2D (median = 6) and 3D tumor spheroids (median = 16) and how this influences virus spread and the outcome of therapy. The parameter range leading to tumor eradication is small and even harder to achieve in 3D. The lower efficiency in 3D exists despite the presence of many more adjacent cells in the 3D environment that results in a shorter time to reach equilibrium. The mean field mathematical models generally used to describe tumor virotherapy appear to provide an overoptimistic view of the outcomes of therapy. Three dimensional space provides a significant barrier to efficient and complete virus spread within tumors and needs to be explicitly taken into account for virus optimization to achieve the desired outcome of therapy. Tumor therapy with replicating oncolytic viruses is based on the premise that if the tumor specific virus infects and is amplified by the tumor population and spreads sufficiently within the tumor, it will lead to eradication of the cancer. The outcome of this approach is an exercise in population dynamics, and, as in ecology, depends on the detailed interactions between the various players involved. Mathematical models have been used to capture these dynamics, but space is often explicitly excluded from these models. We combine in vitro experiments studying tumor growth and virus spread in two and three dimensions to inform the development of a spatially explicit computational model of tumor virotherapy and compare the outcome with non-spatial, mean-field models. Viruses generally spread from cell to cell, and therefore the number of nearest neighbors close to an infected cell is important. Experimental data show that in three dimensions, the median number of nearest neighbors is 16 compared to 6 in the 2D plane. However, while simulations in 3D reach equilibrium faster than in 2D, tumor eradication is much less common in 3D than in 2D. Three dimensional space plays a critical role in the outcome of tumor virotherapy and this additional spatial dimension cannot be ignored in modeling.
- Open Access
- 1 March 2019
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 12, 68-78
In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
- 1 March 2019
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 12, 68-78
Open AccessIn Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
- 15 February 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 4 (32)
The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network
During αβ T cell development, T cell antigen receptor (TCR) engagement transduces biochemical signals through a protein-protein interaction (PPI) network that dictates dichotomous cell fate decisions. It remains unclear how signal specificity is communicated, instructing either positive selection to advance cell differentiation or death by negative selection. Early signal discrimination might occur by PPI signatures differing qualitatively (customized, unique PPI combinations for each signal), quantitatively (graded amounts of a single PPI series), or kinetically (speed of PPI pathway progression). Using a novel PPI network analysis, we found that early TCR-proximal signals distinguishing positive from negative selection appeared to be primarily quantitative in nature. Furthermore, the signal intensity of this PPI network was used to find an antigen dose that caused a classic negative selection ligand to induce positive selection of conventional αβ T cells, suggesting that the quantity of TCR triggering was sufficient to program selection outcome. Because previous work had suggested that positive selection might involve a qualitatively unique signal through CD3δ, we reexamined the block in positive selection observed in CD3δ0 mice. We found that CD3δ0 thymocytes were inhibited but capable of signaling positive selection, generating low numbers of MHC-dependent αβ T cells that expressed diverse TCR repertoires and participated in immune responses against infection. We conclude that the major role for CD3δ in positive selection is to quantitatively boost the signal for maximal generation of αβ T cells. Together, these data indicate that a quantitative network signaling mechanism through the early proximal TCR signalosome determines thymic selection outcome.
- 15 February 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 4 (32)
The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network
During αβ T cell development, T cell antigen receptor (TCR) engagement transduces biochemical signals through a protein-protein interaction (PPI) network that dictates dichotomous cell fate decisions. It remains unclear how signal specificity is communicated, instructing either positive selection to advance cell differentiation or death by negative selection. Early signal discrimination might occur by PPI signatures differing qualitatively (customized, unique PPI combinations for each signal), quantitatively (graded amounts of a single PPI series), or kinetically (speed of PPI pathway progression). Using a novel PPI network analysis, we found that early TCR-proximal signals distinguishing positive from negative selection appeared to be primarily quantitative in nature. Furthermore, the signal intensity of this PPI network was used to find an antigen dose that caused a classic negative selection ligand to induce positive selection of conventional αβ T cells, suggesting that the quantity of TCR triggering was sufficient to program selection outcome. Because previous work had suggested that positive selection might involve a qualitatively unique signal through CD3δ, we reexamined the block in positive selection observed in CD3δ0 mice. We found that CD3δ0 thymocytes were inhibited but capable of signaling positive selection, generating low numbers of MHC-dependent αβ T cells that expressed diverse TCR repertoires and participated in immune responses against infection. We conclude that the major role for CD3δ in positive selection is to quantitatively boost the signal for maximal generation of αβ T cells. Together, these data indicate that a quantitative network signaling mechanism through the early proximal TCR signalosome determines thymic selection outcome.
- Open Access
- 20 November 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (91) , 36254-36255
Oncolytic virotherapy - in vivo veritas
- 20 November 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (91) , 36254-36255
Open AccessOncolytic virotherapy - in vivo veritas
- 15 October 2018
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (20) , 5992-6000
In Vivo Estimation of Oncolytic Virus Populations within Tumors
The use of replication-competent viruses as oncolytic agents is rapidly expanding, with several oncolytic viruses approved for cancer therapy. As responses to therapy are highly variable, understanding the dynamics of therapy is critical for optimal application of virotherapy in practice. Although mathematical models have been developed to understand the dynamics of tumor virotherapy, a scarcity of in vivo data has made difficult parametrization of these models. To tackle this problem, we studied the in vitro and in vivo spread of two oncolytic measles viruses that induce expression of the sodium iodide symporter (NIS) in cells. NIS expression enabled infected cells to concentrate radioactive isotopes that could be reproducibly and quantitatively imaged using SPECT/CT. We observed a strong linear relationship in vitro between infectious virus particles, viral N and NIS gene expression, and radioactive isotope uptake. In vivo radioisotope uptake was highly correlated with viral N and NIS gene expression. Similar expression patterns between viral N and NIS gene expression in vitro and in vivo implied that the oncolytic virus behaved similarly in both scenarios. Significant titers of viable virus were consistently isolated from tumors explanted from mice that had been injected with oncolytic measle viruses. We observed a weaker but positive in vivo relationship between radioisotope uptake and the viable virus titer recovered from tumors; this was likely due to anisotropies in the viral distribution in vivo. These data suggest that methods that enable quantitation of in vivo anisotropies are required for continuing development of oncolytic virotherapy. Significance: These findings address a fundamental gap in our knowledge of oncolytic virotherapy by presenting technology that gives insight into the behavior of oncolytic viruses in vivo. Cancer Res; 78(20); 5992–6000. ©2018 AACR.
- 15 October 2018
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (20) , 5992-6000
In Vivo Estimation of Oncolytic Virus Populations within Tumors
The use of replication-competent viruses as oncolytic agents is rapidly expanding, with several oncolytic viruses approved for cancer therapy. As responses to therapy are highly variable, understanding the dynamics of therapy is critical for optimal application of virotherapy in practice. Although mathematical models have been developed to understand the dynamics of tumor virotherapy, a scarcity of in vivo data has made difficult parametrization of these models. To tackle this problem, we studied the in vitro and in vivo spread of two oncolytic measles viruses that induce expression of the sodium iodide symporter (NIS) in cells. NIS expression enabled infected cells to concentrate radioactive isotopes that could be reproducibly and quantitatively imaged using SPECT/CT. We observed a strong linear relationship in vitro between infectious virus particles, viral N and NIS gene expression, and radioactive isotope uptake. In vivo radioisotope uptake was highly correlated with viral N and NIS gene expression. Similar expression patterns between viral N and NIS gene expression in vitro and in vivo implied that the oncolytic virus behaved similarly in both scenarios. Significant titers of viable virus were consistently isolated from tumors explanted from mice that had been injected with oncolytic measle viruses. We observed a weaker but positive in vivo relationship between radioisotope uptake and the viable virus titer recovered from tumors; this was likely due to anisotropies in the viral distribution in vivo. These data suggest that methods that enable quantitation of in vivo anisotropies are required for continuing development of oncolytic virotherapy. Significance: These findings address a fundamental gap in our knowledge of oncolytic virotherapy by presenting technology that gives insight into the behavior of oncolytic viruses in vivo. Cancer Res; 78(20); 5992–6000. ©2018 AACR.
- 1 September 2018
- Published by Elsevier in Theoretical Population Biology
- Vol. 123, 35-44
Harnessing uncertainty to approximate mechanistic models of interspecific interactions
- 1 September 2018
- Published by Elsevier in Theoretical Population Biology
- Vol. 123, 35-44
Harnessing uncertainty to approximate mechanistic models of interspecific interactions